Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1851-1860 of 2919 for cancer

Edit search filters
  1. Trametinib, Combination Chemotherapy, And Radiation Therapy In Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery

    Rochester, MN

  2. A Study To Evaluate Preoperative Oral Microbiota-Based Investigational New Drug To Target Immune Response In Patients With Operable Stage I-III Breast Cancer

    Jacksonville, FL

  3. A Study Of Rovalpituzumab Tesirine As Maintenance Therapy Following First-Line Platinum-Based Chemotherapy In Participants With Extensive Stage Small Cell Lung Cancer (MERU)

    Rochester, MN

  4. A Study Of Rucaparib In Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer (ARIEL2)

    Jacksonville, FL, Rochester, MN

  5. Suppression Of Ovarian Function With Either Tamoxifen Or Exemestane Compared With Tamoxifen Alone In Treating Premenopausal Women With Hormone-Responsive Breast Cancer

    Eau Claire, WI

  6. COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment Of Liver Metastases In A Randomized, Double-blind, Placebo‑Controlled Phase-III STudy

    Rochester, MN

  7. Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Paclitaxel-Induced Acute Pain Syndrome (P-APS): A Randomized Placebo-Controlled, Double Blind Trial

    Rochester, MN

  8. Safety And Efficacy Study Of MLN0128 In Combination With Exemestane Or Fulvestrant In Postmenopausal Women With ER/PR+ Metastatic Breast Cancer

    Rochester, MN

  9. Phase III Open Label First Line Therapy Study Of MEDI 4736 (Durvalumab) With Or Without Tremelimumab Versus SOC In Non Small-Cell Lung Cancer (NSCLC).

    Scottsdale/Phoenix, AZ

  10. Dose Escalation And Double-blind Study Of Veliparib In Combination With Carboplatin And Etoposide In Treatment-naive Extensive Stage Disease Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer